Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
34.89
+0.88 (2.59%)
At close: Apr 28, 2026, 4:00 PM EDT
34.68
-0.21 (-0.60%)
After-hours: Apr 28, 2026, 4:26 PM EDT
Astrana Health Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Astrana Health stock have an average target of 34.86, with a low estimate of 26 and a high estimate of 40. The average target predicts a decrease of -0.09% from the current stock price of 34.89.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 0 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $37 → $40 | Buy | Maintains | $37 → $40 | +14.65% | Apr 15, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $37 → $38 | Strong Buy | Maintains | $37 → $38 | +8.91% | Mar 13, 2026 |
| BTIG | BTIG | Strong Buy Maintains $45 → $40 | Strong Buy | Maintains | $45 → $40 | +14.65% | Feb 2, 2026 |
| Needham | Needham | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | -19.75% | Dec 12, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $44 → $37 | Strong Buy | Maintains | $44 → $37 | +6.05% | Nov 25, 2025 |
Financial Forecast
Revenue This Year
4.05B
from 3.18B
Increased by 27.38%
Revenue Next Year
4.49B
from 4.05B
Increased by 10.78%
EPS This Year
1.26
from 0.46
Increased by 174.79%
EPS Next Year
1.92
from 1.26
Increased by 52.84%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 4.3B | 4.8B | ||||
| Avg | 4.1B | 4.5B | ||||
| Low | 3.7B | 4.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 35.1% | 18.6% | ||||
| Avg | 27.4% | 10.8% | ||||
| Low | 17.8% | 1.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.51 | 2.33 | |
| Avg | 1.26 | 1.92 | |
| Low | 1.01 | 1.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 230.0% | 85.1% | |
| Avg | 174.8% | 52.8% | |
| Low | 120.3% | 26.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.